PentaBind

PentaBind

Biotechnology Research

A platform TechBio company using Generative AI to unlock new therapeutics

About us

PentaBind is a VC-backed drug discovery company using Artificial Intelligence and an integrated wet-laboratory to design high performance aptamers with multiple drug-like qualities in one step. They develop their own pipeline therapeutic assets with aptamers as an active ingredient and aptamers as a delivery vehicle. Shortlisted as New Startup of the Year by Cancer Research Horizons. PentaBind is is supported by Entrepreneur First VC, Twin Path, P4SY, Panacea Stars, Stevenage Bioscience Catalyst, Science Creates Accelerator, Science Entrepreneur Club, and KQ Labs (the Francis Crick Institute). For more information or to join our mission: contact@PentaBind.com ***We are hiring Computational Biologists, Molecular Biologists, Protein and Data Engineers. Don't hesitate to reach out!***

Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
London
Type
Privately Held
Founded
2021

Locations

Employees at PentaBind

Updates

Similar pages

Browse jobs

Funding

PentaBind 3 total rounds

Last Round

Seed

US$ 845.0K

See more info on crunchbase